2BBBullish & Bearish
Health Care

Immunome, Inc. (IMNM) Stock Score & Signals

Immunome, Inc. (IMNM) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 56 out of 100.

2BB score and signals

Immunome, Inc.’s current 2BB score is 56 out of 100, built from the signal categories below.

SignalScoreReading
Activity78High
Momentum61Improving
Financial strength13Very Weak
Quality97Very Strong
Risk41Moderate

Company facts

HeadquartersBothell, Washington, United States
Founded2006
Employees247
52-week range$13.94 – $30.06

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-03-01—-0.6538—$185,456.00
2026-11-04—-0.6311—$185,456.00
2026-08-19—-0.5326—$185,456.00
2026-05-12-0.48-0.5736$0.00$226,664.00